Recall archive / FDA company announcement

Lupin: Quinapril 20 and 40 mg tablets — FDA announcement Dec 21, 2022

Reported terminated

A company announcement posted by FDA. The listing date can differ from the original announcement date. The absence of a termination marker does not prove the recall is currently ongoing.

Source date Dec 21, 2022. Retrieved Oct 1, 2026. Last updated Oct 1, 2026.

Archive changed Oct 1, 2026. USDA FSIS records are unavailable; check FSIS directly. Source coverage and dates.

What the record says

Product: Quinapril 20 and 40 mg tablets
Reason: Presence of nitrosamine impurity, N-Nitroso-Quinapril
Classification: Not supplied
Recalling firm: Lupin Pharmaceuticals Inc.
Quantity: Not supplied
Agency-reported status: Terminated in FDA listing
Source record identifier: cb338067c2d67f7c

Open the official record

Lot and product identifiers

Label field	Details supplied by the agency
Lot, code or applicability	Consumers, wholesalers, distributors, and retailers with questions regarding this recall should contact Inmar Rx Solutions, Inc. at (877) 538-8445 Monday – Friday 09:00 am to 05:00 pm EST. For reimbursement, please have the recalled lots returned to Inmar Rx Solutions, Inc.; the lot number can be found on the side of the bottle label.; Product \| Lot No \| Expiry \| NDC \| UPC \| Distribution Dates; Quinapril Tablets USP, 20mg \| G102929 \| 04/2023 \| 68180-558-09 (90’s) \| 368180558095 \| 03/15/2021 – 09/01/2022; Quinapril Tablets USP, 40mg \| G100533 G100534 G203071 \| 12/2022 12/2022 03/2024 \| 68180-554-09 (90’s) \| 368180554097

Label field

Details supplied by the agency

Lot, code or applicability

Consumers, wholesalers, distributors, and retailers with questions regarding this recall should contact Inmar Rx Solutions, Inc. at (877) 538-8445 Monday – Friday 09:00 am to 05:00 pm EST. For reimbursement, please have the recalled lots returned to Inmar Rx Solutions, Inc.; the lot number can be found on the side of the bottle label.; Product | Lot No | Expiry | NDC | UPC | Distribution Dates; Quinapril Tablets USP, 20mg | G102929 | 04/2023 | 68180-558-09 (90’s) | 368180558095 | 03/15/2021 – 09/01/2022; Quinapril Tablets USP, 40mg | G100533 G100534 G203071 | 12/2022 12/2022 03/2024 | 68180-554-09 (90’s) | 368180554097

Match all identifying details in the current notice. A brand name alone is not enough.

Product tables from the announcement

These identifying details come from the company announcement posted by FDA. Check the current notice for revisions.

FDA company announcement, table 1
Product	Lot No	Expiry	NDC	UPC	Distribution Dates
Quinapril Tablets USP, 20mg	G102929	04/2023	68180-558-09 (90’s)	368180558095	03/15/2021 – 09/01/2022
Quinapril Tablets USP, 40mg	G100533 G100534 G203071	12/2022 12/2022 03/2024	68180-554-09 (90’s)	368180554097	03/15/2021 – 09/01/2022

Announcement retrieved Oct 1, 2026. Official announcement.

Distribution

Not supplied

No US distribution state could be established from this record. Check the official notice.

Dates in the source

Fda listing date: Dec 21, 2022
Company announcement date: Dec 21, 2022

FDA company pages use the listing date; enforcement records use initiation dates; CPSC uses recall date; NHTSA uses report-received date. These dates are not interchangeable.